Author Archives for Lea Scheppke

Interview with Emily Y. Chew, MD

June 16, 2016 9:03 am Published by Lea Scheppke

Dr. Emily Y. Chew, MD is the Deputy Director of the Division of Epidemiology and Clinical Applications at the National... View Article

Interview with June Blades

June 16, 2016 8:38 am Published by Lea Scheppke

On the Diagnosis: How long has it been since you were diagnosed with MacTel? I was diagnosed with macular telangiectasia... View Article

Retinal Vascular Layers in Macular Telangiectasia type 2 Imaged by Optical Coherence Tomographic Angiography

May 31, 2016 10:39 am Published by Lea Scheppke

Spaide RF, Klancnik JM Jr, Cooney MJ.  JAMA Ophthalmol. 2015;133(1):66-73.

Volume-Rendering Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2

May 31, 2016 10:36 am Published by Lea Scheppke

Spaide RF, Klancnik JM Jr, Cooney MJ, Yannuzzi LA, Balaratnasingam C, Dansingani KK, Suzuki M.  Ophthalmology. 2015;122(11):2261-9.

Volume-rendered Angiographic and Structural Optical Coherence Tomography

May 31, 2016 10:34 am Published by Lea Scheppke

Spaide RF. Retina. 2015;35(11):2181-7.

Possible Choroidal Neovascularization in Macular Telangiectasia type 2

May 31, 2016 10:31 am Published by Lea Scheppke

Balaratnasingam C, Yannuzzi LA, Spaide RF.  Retina. 2015;35(11):2317-22.

Interview with Kathy

May 1, 2016 6:00 am Published by Lea Scheppke

On the Diagnosis: When were you were diagnosed with MacTel?    I was diagnosed in January of 2013. What are some... View Article

Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2.

April 5, 2016 11:10 am Published by Lea Scheppke

Roisman L, Rosenfeld PJ.  Dev Ophthalmol. 2016;56:146-58.

Interview with Paul Bernstein, MD, PhD

April 5, 2016 9:23 am Published by Lea Scheppke

Dr. Paul Bernstein is a Professor at the University of Utah, School of Medicine, in the Department of Ophthalmology. Dr. Bernstein is a Lowy Medical Research Institute extramural investigator and clinical researcher. He has been instrumental to MacTel genetics research; recruiting families with MacTel to participate in the MacTel Project. In the laboratory, his research focuses on macular pigment. Changes in macular pigment distribution are among the first clinical signs of MacTel. In this interview, we discuss both his clinical and laboratory work.

Very Early Disease Manifestations of Macular Telangiectasia Type 2

March 30, 2016 10:23 am Published by Lea Scheppke

Charbel Issa, Peter MD, DPhil; Heeren, Tjebo F. C. MD; Kupitz, Elke H. MD; Holz, Frank G. MD; Berendschot, Tos... View Article